TY - JOUR AU - Siegel, R. AU - Ma, J. AU - Zou, Z. AU - Jemal, A. PY - 2014 DA - 2014// TI - Cancer statistics JO - CA Cancer J Clin VL - 64 UR - https://doi.org/10.3322/caac.21208 DO - 10.3322/caac.21208 ID - Siegel2014 ER - TY - JOUR AU - Nik, N. N. AU - Vang, R. AU - Shih, I. M. AU - Kurman, R. J. PY - 2014 DA - 2014// TI - Origin and pathogenesis of pelvic (ovarian, tubal, and primary peritoneal) serous carcinoma JO - Annu Rev Pathol VL - 9 UR - https://doi.org/10.1146/annurev-pathol-020712-163949 DO - 10.1146/annurev-pathol-020712-163949 ID - Nik2014 ER - TY - JOUR AU - Kurman, R. J. AU - Shih, I. e. M. PY - 2008 DA - 2008// TI - Pathogenesis of ovarian cancer: lessons from morphology and molecular biology and their clinical implications JO - Int J Gynecol Pathol VL - 27 ID - Kurman2008 ER - TY - JOUR AU - Kurman, R. J. AU - Shih, I. e. M. PY - 2010 DA - 2010// TI - The origin and pathogenesis of epithelial ovarian cancer: a proposed unifying theory JO - Am J Surg Pathol VL - 34 UR - https://doi.org/10.1097/PAS.0b013e3181cf3d79 DO - 10.1097/PAS.0b013e3181cf3d79 ID - Kurman2010 ER - TY - JOUR AU - Kuhn, E. AU - Kurman, R. J. AU - Vang, R. PY - 2012 DA - 2012// TI - TP53 mutations in serous tubal intraepithelial carcinoma and concurrent pelvic high-grade serous carcinoma-evidence supporting the clonal relationship of the two lesions JO - J Pathol. VL - 226 UR - https://doi.org/10.1002/path.3023 DO - 10.1002/path.3023 ID - Kuhn2012 ER - TY - JOUR AU - Auersperg, N. AU - Ota, T. AU - Mitchell, G. W. PY - 2002 DA - 2002// TI - Early events in ovarian epithelial carcinogenesis: progress and problems in experimental approaches JO - Int J Gynecol Cancer VL - 12 UR - https://doi.org/10.1046/j.1525-1438.2002.01152.x DO - 10.1046/j.1525-1438.2002.01152.x ID - Auersperg2002 ER - TY - JOUR AU - Burleson, K. M. AU - Casey, R. C. AU - Skubitz, K. M. AU - Pambuccian, S. E. AU - Oegema, T. R. AU - Skubitz, A. P. PY - 2004 DA - 2004// TI - Ovarian carcinoma ascites spheroids adhere to extracellular matrix components and mesothelial cell monolayers JO - Gynecol Oncol VL - 93 UR - https://doi.org/10.1016/j.ygyno.2003.12.034 DO - 10.1016/j.ygyno.2003.12.034 ID - Burleson2004 ER - TY - JOUR AU - Cvetkovic, D. PY - 2003 DA - 2003// TI - Early events in ovarian oncogenesis JO - Reprod Biol Endocrinol VL - 1 UR - https://doi.org/10.1186/1477-7827-1-68 DO - 10.1186/1477-7827-1-68 ID - Cvetkovic2003 ER - TY - JOUR AU - Bhowmick, N. A. AU - Neilson, E. G. AU - Moses, H. L. PY - 2004 DA - 2004// TI - Stromal fibroblasts in cancer initiation and progression JO - Nature VL - 432 UR - https://doi.org/10.1038/nature03096 DO - 10.1038/nature03096 ID - Bhowmick2004 ER - TY - JOUR AU - Wels, J. AU - Kaplan, R. N. AU - Rafii, S. AU - Lyden, D. PY - 2008 DA - 2008// TI - Migratory neighbors and distant invaders: tumor-associated niche cells JO - Gene Develop VL - 22 UR - https://doi.org/10.1101/gad.1636908 DO - 10.1101/gad.1636908 ID - Wels2008 ER - TY - JOUR AU - IeM, S. h. i. h. AU - Chen, L. AU - Wang, C. C. AU - Gu, J. AU - Davidson, B. AU - Cope, L. PY - 2010 DA - 2010// TI - Distinct DNA methylation profiles in ovarian serous neoplasms and their implications in ovarian carcinogenesis JO - Am J Obstet Gynecol VL - 203 ID - IeM2010 ER - TY - JOUR AU - Dai, W. AU - Zeller, C. AU - Masrour, N. AU - Siddiqui, N. AU - Paul, J. AU - Brown, R. PY - 2013 DA - 2013// TI - Promoter CpG Island Methylation of genes in key cancer pathways associates with clinical outcome in high-grade serous ovarian cancer JO - Clin Cancer Res VL - 19 UR - https://doi.org/10.1158/1078-0432.CCR-13-1217 DO - 10.1158/1078-0432.CCR-13-1217 ID - Dai2013 ER - TY - JOUR AU - Barton, C. A. AU - Hacker, N. F. AU - Clark, S. J. AU - O’Brien, P. M. PY - 2008 DA - 2008// TI - DNA methylation changes in ovarian cancer: implications for early diagnosis, prognosis and treatment JO - Gynecol Oncol VL - 109 UR - https://doi.org/10.1016/j.ygyno.2007.12.017 DO - 10.1016/j.ygyno.2007.12.017 ID - Barton2008 ER - TY - JOUR AU - Balch, C. AU - Fang, F. AU - Matei, D. E. AU - Huang, T. H. AU - Nephew, K. P. PY - 2009 DA - 2009// TI - Minireview: epigenetic changes in ovarian cancer JO - Endocrinol VL - 150 UR - https://doi.org/10.1210/en.2009-0404 DO - 10.1210/en.2009-0404 ID - Balch2009 ER - TY - JOUR AU - Li, Y. AU - Hu, W. AU - Shen, D. Y. AU - Kavanagh, J. J. AU - Fu, S. PY - 2000 DA - 2000// TI - Azacitidine enhances sensitivity of platinum-resistant ovarian cancer cells to carboplatin through induction of apoptosis JO - Am J Obstetet Gynecol VL - 200 ID - Li2000 ER - TY - JOUR AU - Li, M. AU - Balch, C. AU - Montgomery, J. S. AU - Jeong, M. AU - Chung, J. H. AU - Yan, P. PY - 2009 DA - 2009// TI - Integrated analysis of DNA methylation and gene expression reveals specific signaling pathways associated with platinum resistance in ovarian cancer JO - BMC Med Genomics VL - 2 UR - https://doi.org/10.1186/1755-8794-2-34 DO - 10.1186/1755-8794-2-34 ID - Li2009 ER - TY - JOUR AU - Matei, D. AU - Fang, F. AU - Shen, C. AU - Schilder, J. AU - Arnold, A. AU - Zeng, Y. PY - 2012 DA - 2012// TI - Epigenetic resensitization to platinum in ovarian cancer JO - Cancer Res VL - 72 UR - https://doi.org/10.1158/0008-5472.CAN-11-3909 DO - 10.1158/0008-5472.CAN-11-3909 ID - Matei2012 ER - TY - JOUR AU - Plumb, J. A. AU - Strathdee, G. AU - Sludden, J. AU - Kaye, S. B. AU - Brown, R. PY - 2000 DA - 2000// TI - Reversal of drug resistance in human tumor xenografts by 20-deoxy-5-azacytidine induced demethylation of the hMLH1 gene promoter JO - Cancer Res VL - 60 ID - Plumb2000 ER - TY - JOUR AU - Teng, I. W. AU - Hou, P. C. AU - Lee, K. D. AU - Chu, P. Y. AU - Yeh, K. T. AU - Jin, V. X. PY - 2012 DA - 2012// TI - Targeting the unique methylation pattern of androgen receptor (AR) promoter in prostate stem/progenitor cells with 5-aza-2′-deoxycytidine (5-AZA) leads to suppressed prostate tumorigenesis JO - J Biol Chem VL - 16 ID - Teng2012 ER - TY - JOUR AU - Karnoub, A. E. AU - Dash, A. B. AU - Vo, A. P. AU - Sullivan, A. AU - Brooks, M. W. AU - Bell, G. W. PY - 2007 DA - 2007// TI - Mesenchymal stem cells within tumour stroma promote breast cancer metastasis JO - Nature VL - 449 UR - https://doi.org/10.1038/nature06188 DO - 10.1038/nature06188 ID - Karnoub2007 ER - TY - JOUR AU - Muehlberg, F. L. AU - Song, Y. H. AU - Krohn, A. AU - Pinilla, S. P. AU - Droll, L. H. AU - Leng, X. PY - 2009 DA - 2009// TI - Tissue-resident stem cells promote breast cancer growth and metastasis JO - Carcinogenesis VL - 30 UR - https://doi.org/10.1093/carcin/bgp036 DO - 10.1093/carcin/bgp036 ID - Muehlberg2009 ER - TY - JOUR AU - Spaeth, E. L. AU - Dembinski, J. L. AU - Sasser, A. K. AU - Watson, K. AU - Klopp, A. AU - Hall, B. PY - 2009 DA - 2009// TI - Mesenchymal stem cell transition to tumor-associated fibroblasts contributes to fibrovascular network expansion and tumor progression JO - PLoS One VL - 4 UR - https://doi.org/10.1371/journal.pone.0004992 DO - 10.1371/journal.pone.0004992 ID - Spaeth2009 ER - TY - JOUR AU - McLean, K. AU - Gong, Y. AU - Choi, Y. AU - Deng, N. AU - Yang, K. AU - Bai, S. PY - 2011 DA - 2011// TI - Human ovarian carcinoma–associated mesenchymal stem cells regulate cancer stem cells and tumorigenesis via altered BMP production JO - J Clin Invest. VL - 121 UR - https://doi.org/10.1172/JCI45273 DO - 10.1172/JCI45273 ID - McLean2011 ER - TY - JOUR AU - Ho, C. M. AU - Chang, S. F. AU - Hsiao, C. C. AU - Chien, T. Y. AU - Shih, D. T. PY - 2012 DA - 2012// TI - Isolation and characterization of stromal progenitor cells from ascites of patients with epithelial ovarian adenocarcinoma JO - J Biomed Sci VL - 14 ID - Ho2012 ER - TY - JOUR AU - Zuk, P. A. AU - Zhu, M. AU - Ashjian, P. AU - Ugarte, D. A. AU - Huang, J. I. AU - Mizuno, H. PY - 2002 DA - 2002// TI - Human adipose tissue is a source of multipotent stem cells JO - Mol Biol Cell VL - 13 UR - https://doi.org/10.1091/mbc.E02-02-0105 DO - 10.1091/mbc.E02-02-0105 ID - Zuk2002 ER - TY - JOUR AU - Ho, C. M. AU - Huang, C. J. AU - Huang, C. Y. AU - Wu, Y. Y. AU - Chang, S. F. AU - Cheng, W. F. PY - 2012 DA - 2012// TI - Promoter Methylation status of HIN-1 associated with outcomes of ovarian clear cell adenocarcinoma JO - Mol Cancer VL - 11 UR - https://doi.org/10.1186/1476-4598-11-53 DO - 10.1186/1476-4598-11-53 ID - Ho2012 ER - TY - JOUR AU - Castro, M. AU - Grau, L. AU - Puerta, P. AU - Gimenez, L. AU - Venditti, J. AU - Quadrelli, S. PY - 2002 DA - 2002// TI - Multiplexed methylation profiles of tumor suppressor genes and clinical outcome in lung cancer JO - J Transl Med VL - 8 UR - https://doi.org/10.1186/1479-5876-8-86 DO - 10.1186/1479-5876-8-86 ID - Castro2002 ER - TY - JOUR AU - Bol, G. M. AU - Suijkerbuijk, K. P. AU - Bart, J. AU - Vooijs, M. AU - Wall, E. AU - Diest, P. J. PY - 2010 DA - 2010// TI - Methylation profiles of hereditary and sporadic ovarian cancer JO - Histopathology VL - 57 UR - https://doi.org/10.1111/j.1365-2559.2010.03642.x DO - 10.1111/j.1365-2559.2010.03642.x ID - Bol2010 ER - TY - JOUR AU - Meng, F. AU - Sun, G. AU - Zhong, M. AU - Yu, Y. AU - Brewer, M. A. PY - 2013 DA - 2013// TI - Inhibition of DNA methyltransferases, histone deacetylases and lysine-specific demethylase-1 suppresses the tumorigenicity of the ovarian cancer ascites cell line SKOV3 JO - Int J Oncol VL - 43 ID - Meng2013 ER - TY - JOUR AU - Tu, S. M. AU - Lin, S. H. AU - Logothetis, C. J. PY - 2002 DA - 2002// TI - Stem-cell origin of metastasis and heterogeneity in solid tumours JO - Lancet Oncol VL - 3 UR - https://doi.org/10.1016/S1470-2045(02)00820-3 DO - 10.1016/S1470-2045(02)00820-3 ID - Tu2002 ER - TY - JOUR AU - Tsai, H. C. AU - Li, H. AU - Neste, L. AU - Cai, Y. AU - Robert, C. AU - Rassool, F. V. PY - 2012 DA - 2012// TI - Transient low doses of DNA-demethylating agents exert durable antitumor effects on hematological and epithelial tumor cells JO - Cancer Cell VL - 21 UR - https://doi.org/10.1016/j.ccr.2011.12.029 DO - 10.1016/j.ccr.2011.12.029 ID - Tsai2012 ER - TY - JOUR AU - Tian, J. AU - Lee, S. O. AU - Liang, L. AU - Luo, J. AU - Huang, C. K. AU - Li, L. PY - 2012 DA - 2012// TI - Targeting the unique methylation pattern of androgen receptor (AR) promoter in prostate stem/progenitor cells with 5-aza-2′-deoxycytidine (5-AZA) leads to suppressed prostate tumorigenesis JO - J Biol Chem VL - 287 UR - https://doi.org/10.1074/jbc.M112.395574 DO - 10.1074/jbc.M112.395574 ID - Tian2012 ER - TY - JOUR AU - Park, I. H. AU - Zhao, R. AU - West, J. A. AU - Yabuuchi, A. AU - Huo, H. AU - Ince, T. A. PY - 2008 DA - 2008// TI - Reprogramming of human somatic cells to pluripotency with defined factors JO - Nature VL - 451 UR - https://doi.org/10.1038/nature06534 DO - 10.1038/nature06534 ID - Park2008 ER - TY - JOUR AU - Altun, G. AU - Loring, J. F. AU - Laurent, L. C. PY - 2010 DA - 2010// TI - DNA methylation in embryonic stem cells JO - J Cell Biochem VL - 109 ID - Altun2010 ER - TY - JOUR AU - Deonarain, M. P. AU - Kousparou, C. A. AU - Epenetos, A. A. PY - 2009 DA - 2009// TI - Antibodies targeting cancer stem cells. A new paradigm in immunotherapy? JO - Mabs VL - 1 UR - https://doi.org/10.4161/mabs.1.1.7347 DO - 10.4161/mabs.1.1.7347 ID - Deonarain2009 ER - TY - JOUR AU - Sims-Mourtada, J. AU - Izzo, J. G. AU - Ajani, J. AU - Chao, K. S. PY - 2007 DA - 2007// TI - Sonic Hedgehog promotes multiple drug resistance by regulation of drug transport JO - Oncogene VL - 26 UR - https://doi.org/10.1038/sj.onc.1210356 DO - 10.1038/sj.onc.1210356 ID - Sims-Mourtada2007 ER - TY - JOUR AU - Mimeault, M. AU - Johansson, S. L. AU - Batra, S. K. PY - 2012 DA - 2012// TI - Pathobiological implications of the expression of EGFR, pakt, NF-KB and MIC-1 in prostate cancer stem cells and their progenies JO - PLoS One VL - 7 UR - https://doi.org/10.1371/journal.pone.0031919 DO - 10.1371/journal.pone.0031919 ID - Mimeault2012 ER - TY - JOUR AU - Clevers, H. PY - 2011 DA - 2011// TI - The cancer stem cell: premises, promises and challenges JO - Nature Med VL - 17 UR - https://doi.org/10.1038/nm.2304 DO - 10.1038/nm.2304 ID - Clevers2011 ER - TY - JOUR AU - Fu, S. AU - Hu, W. AU - Iyer, R. AU - Kavanagh, J. J. AU - Coleman, R. L. AU - Levenback, C. F. PY - 2011 DA - 2011// TI - Phase 1b-2a study to reverse platinum resistance through use of a hypomethylating agent, azacitidine, in patients with platinum-resistant or platinum-refractory epithelial ovarian cancer JO - Cancer VL - 117 UR - https://doi.org/10.1002/cncr.25701 DO - 10.1002/cncr.25701 ID - Fu2011 ER -